Therapeutic inhibition of chemerin, such as with cornelian cherry extract, attenuated trinitrobenzene sulfonic acid (TNBS) colitis by reducing TNF-α, IL-17, and chemerin, strengthening epithelial barrier integrity and limiting pathogenic E. coli [88]. The gene discussed is RARRES2; the disease is colitis.